Skip to content

Advertisement

  • Methodology article
  • Open Access

DNA sequence-based re-assessment of archived Cronobacter sakazakii strains isolated from dairy products imported into China between 2005 and 2006

Contributed equally
BMC Genomics201819:506

https://doi.org/10.1186/s12864-018-4881-9

Received: 23 February 2018

Accepted: 18 June 2018

Published: 28 June 2018

Abstract

Background

Cronobacter species are associated with severe foodborne infections in neonates and infants, with particular pathovars associated with specific clinical presentations. However, before 2008 the genus was regarded as a single species named Enterobacter sakazakii which was subdivided into 8 phenotypes. This study re-analyzed, using multi-locus sequence typing (MLST) and whole genome sequence with single nucleotide polymorphism analysis (WGS-SNP), 52 strains which had been identified as Enterobacter sakazakii as according to the convention at the time of isolation. These strains had been isolated from dairy product imports into China from 9 countries between 2005 and 6. Bioinformatic analysis was then used to analyze the relatedness and global dissemination of these strains.

Result

FusA allele sequencing revealed that 49/52 strains were Cronobacter sakazakii, while the remaining 3 strains were Escherichia coli, Enterobacter cloacae, and Franconibacter helveticus. The C. sakazakii strains comprised of 8 sequence types (STs) which included the neonatal pathovars ST1, ST4 and ST12. The predominant sequence type was ST13 (65.3%, 32/49) which had been isolated from dairy products imported from 6 countries. WGS-SNP analysis of the 32 C. sakazakii ST13 strains revealed 5 clusters and 5 unique strains which did not correlate with the country of product origin.

Conclusion

The mis-identification of E. coli, E. cloacae and F. helveticus as Cronobacter spp. reinforces the need to apply reliable methods to reduce the incidence of false positive and false negative results which may be of clinical significance. The WGS-SNP analysis demonstrated that indistinguishable Cronobacter strains within a sequence type can be unrelated, and may originate from multiple sources. The use of WGS-SNP analysis to distinguishing of strains within a sequence type has important relevance for tracing the source of outbreaks due to Cronobacter spp.

Keywords

  • Cronobacter sakazakii
  • MLST
  • WGS
  • SNP analysis
  • Dairy products
  • Traceability

Background

Until 2007 the Cronobacter genus was known as the single species Enterobacter sakazakii. The organism is a member of the Enterobacteriaceae, and are facultative anaerobic, oxidase-negative, catalase-positive, rod-shaped, motile, non-spore-formers [1]. About 80% of strains produce a yellow pigment at room temperature [1]. The Cronobacter genus is composed of seven species, namely C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, C. dublinensis, C. universalis, and C. condimenti [1, 2]. However, C. sakazakii and C. malonaticus are particularly associated with infant and adult infections, respectively [35]. Most Cronobacter infections are in the adult population and are non-life threatening; however, there is a high fatality rate (40–80%) and permanent neurological sequelae following Cronobacter infections of pre-term, low-birth-weight neonates and infants [6, 7]. C. sakazakii is the species of most concern in neonatal and infant infections as it is linked to cases of meningitis, sepsis and necrotizing enterocolitis. Reconstituted powdered infant formula (PIF) and contaminated expressed breast milk have been implicated as the sources of Cronobacter infection in a number of neonatal and infant cases [4]. According to Minor et al. (2015), Cronobacter is the most expensive food-associated infection due to the loss of life and debilitation of survivors, each case being estimated to cost $1 million USD [8].

Cronobacter species are ubiquitous and have been isolated from a variety of foods including PIF, dairy products, dairy product ingredients, ready-to-eat foods and various environmental sources including hospital air, water and equipment used for PIF reconstitution, and milk powder manufacturing plants [912]. The organism can survive for more than two years in a desiccated environment such as PIF [13].

In 2002, the International Commission on Microbiological Specifications for Foods (ICMSF) designated Cronobacter, then known as E. sakazakii, as a severe hazard for restricted populations of immunocompromised individuals such as neonates and infants [14, 15]. Since the organism is foodborne, the Food and Drug Administration (FDA) in China has proposed that the organism should be absent in infant feeds.

Since the mid-1990s, China has been a net-importer of dairy products, and this increased in 2004 following domestic dairy-safety incidents. Dairy products in China are mainly imported from New Zealand, Australia, France, Germany, and the United States. In these countries a number of clinical outbreaks of neonatal infections have been reported which were attributed to Cronobacter contaminated reconstituted PIF [6, 7, 1618]. It is therefore plausible that bacterially contaminated PIF was exported from these countries. However, to date, no data has been collated on Cronobacter spp. isolated from dairy products imported into China. This would be useful for microbial source tracking of Cronobacter through contaminated dairy products, and subsequently reduce future risk of neonatal and infant infections.

Previously, pulsed-field gel electrophoresis (PFGE) was regarded as a gold-standard method for molecular-epidemiological investigations of the outbreaks of pathogens [19]. However, PFGE analysis has several limitations including being unable to distinguish between unrelated strains of highly clonal organisms such as Cronobacter spp. [20]. Due to such issues, FoodNet is transitioning away from PFGE to WGS-SNP for its epidemiological analysis of foodborne outbreaks [21, 22].

Whole genome comparisons reveal a plethora of genetic polymorphisms that can be used for fast and accurate discrimination of infection-associated isolates; even down to the single strain level. WGS offers a higherresolution of the genetic relatedness of isolates than did PFGE and provides additional information regarding multi-locus sequence type (MLST), CRISPR-cas arrays, single nucleotide polymorphisms (SNPs), pathogenicity genes, and detailed molecular characterization of strains [1, 23].

There are several examples of comparison studies between conventional bacterial genotyping and WGS in the literature. Lytsy et al. (2017) compared the reliability, resolution, and applicability of PFGE, WGS and MLST for vancomycin-resistant enterococci (VRE), leading to the recommend of WGS-ANI analysis for epidemiological issues of VRE [24]. McRobb et al. (2015) combined whole-genome indel analysis and SNP phylogeny for Burkholderia pseudomallei, which provided greater resolution and a better fit with the epidemiological chronology of events [25]. Ferdous et al. (2016) undertook WGS analysis of 132 shiga toxin-producing E. coli (STEC) isolates [26]. These isolates constituted 44 sequence types (STs), 42 serogenotypes and 14 stx subtype combinations. Such studies demonstrate the application of WGS to the microbial source tracking and risk assessment. This comparative WGS study of C. sakazakii isolates from dairy products collected over 2 years is expected to be similarly informative and useful.

The aim of this work was to re-identify and genotype, using 7-loci MLST and WGS, bacterial isolates from imported dairy products which had previously been identified as E. sakazakii. SNP analysis was then used to distinguish between strains within the predominant sequence type, C. sakazakii ST13, which had been originally isolated from various dairy products originating from six countries.

Method

Dairy product sample collection

The origin of the isolates used in this study is given in Table 1. These isolates had been obtained from imported dairy products which had been sampled at the Shanghai Entry-Exit Inspection and Quarantine Bureau between 2005 and 2006. A total of 52 imported dairy products, including PIF, raw dairy product ingredients, cheeses, milk powder and other dairy items collected were found to be contaminated by the organism then known as E. sakazakii. For the purposes of understanding discrepancies in the identification of these strains, the original isolation and identification methods used by previous workers are described below.
Table 1

Detail information of all isolates, Clustering of Cronobacter sequence type by MLST and O-serotypes according to gnd and galF sequence analysis

Isolate

PubMLST ID number

API20E bionumber

Organism

ST

O-serotypea

galF loci

gnd loci

Source

Country

Year

CS-6

1956

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2005

CS-8

1957

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2005

CS-25

1967

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2005

CS-30

1968

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2005

CS-36

1972

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2006

CS-45

1978

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2006

CS-48

1980

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2006

CS-52

1983

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2006

CS-72

2000

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

New Zealand

2006

CS-2

1953

06257300153722011

C. sakazakii

13

O:2

25

28

Powdered infant formula

Netherlands

2005

CS-1

1952

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

USA

2005

CS-62

1992

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

USA

2006

CS-65

1995

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

USA

2006

CS-66

1996

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

USA

2006

CS-9

1958

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

New Zealand

2005

CS-17

1963

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

Australia

2005

CS-47

1979

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

France

2006

CS-64

1994

06257300153722011

C. sakazakii

13

O:2

25

28

Dairy product ingredient

Belgium

2006

CS-18

1964

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

New Zealand

2005

CS-19

1965

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

New Zealand

2005

CS-61

1991

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

New Zealand

2006

CS-56

1987

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

New Zealand

2006

CS-60

1990

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

New Zealand

2006

CS-14

1961

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

USA

2005

CS-71

1999

06257300153722011

C. sakazakii

13

O:2

25

28

Milk powder

France

2006

CS-34

1971

06257300153722011

C. sakazakii

13

O:2

25

28

Cheese

Australia

2006

CS-37

1973

06257300153722011

C. sakazakii

13

O:2

25

28

Cheese

Australia

2006

CS-38

1974

06257300153722011

C. sakazakii

13

O:2

25

28

Cheese

Australia

2006

CS-33

1970

06257300153722011

C. sakazakii

13

O:2

25

28

Cheese

France

2006

CS-44

1977

06257300153722011

C. sakazakii

13

O:2

25

28

Cheese

France

2006

CS-32

1969

06257300153722011

C. sakazakii

13

O:2

25

28

Other dairy products

New Zealand

2005

CS-63

1993

06257300153722011

C. sakazakii

13

O:2

25

28

Other dairy products

USA

2006

CS-13

1960

06257300153722011

C. sakazakii

4

O:2

3

2

Dairy product ingredient

USA

2005

CS-54

1985

06257300153722011

C. sakazakii

4

na

4

45/46

Dairy product ingredient

USA

2006

CS-15

1962

06257300153722011

C. sakazakii

4

O:2

3

2

Other dairy products

USA

2005

CS-58

1989

06257300153722011

C. sakazakii

4

na

4

45/46

Other dairy products

New Zealand

2006

CS-70

1998

06257300153722011

C. sakazakii

4

O:2

3

2

Milk powder

New Zealand

2006

CS-43

1976

06257300153722011

C. sakazakii

4

O:2

3

2

Cheese

Italy

2006

CS-55

1986

06257300153722011

C. sakazakii

375

na

26

67

Dairy product ingredient

New Zealand

2006

CS-53

1984

06257300153722011

C. sakazakii

375

na

26

67

Other dairy products

New Zealand

2006

CS-5

1955

06257300153722011

C. sakazakii

375

na

26

67

Dairy product ingredient

Poland

2005

CS-10

1959

06257300153722011

C. sakazakii

375

na

26

67

Other dairy products

Poland

2005

CS-49

1981

06257300153722011

C. sakazakii

1

O:1

2

1

Whole milk powder

New Zealand

2006

CS-24

1966

06257300153722011

C. sakazakii

1

O:1

2

1

Other dairy products

New Zealand

2005

CS-67

1997

06257300153722011

C. sakazakii

21

O:1

19

21

Dairy product ingredient

Canada

2006

CS-42

1975

06257300153722011

C. sakazakii

21

O:1

19

21

Other dairy products

Canada

2006

CS-51

1982

06257300153722011

C. sakazakii

12

na

26

62

Other dairy products

New Zealand

2006

CS-4

1954

06257300153722011

C. sakazakii

42

na

/

/

Dairy product ingredient

Poland

2005

CS-57

1988

06257300153722011

C. sakazakii

233

na

47

47

Other dairy products

New Zealand

2006

CS-22

2449

2,405,610,540,464,611

E. coli

na

na

na

na

Dairy product ingredient

France

2005

CS-35

2451

0627634553532210

E. cloacae

na

na

na

na

Powdered infant formula

Netherlands

2006

CS-23

2450

0605710142500210

F. helveticus

na

na

na

na

Powdered infant formula

New Zealand

2005

aThe O-serotype was predicted using the whole genome sequence by comparison with the defined C. sakazakii O-serotype regions in Cronobacter database [34]

bna not applicable

Original E. sakazakii isolation procedures

The dairy products had been analyzed as according to the then recommended methods of the US FDA and Health Canada’s Department of Health Products and Food [2730]. Samples (40 g) were placed in an Erlenmeyer flask containing 360 ml of sterilized water which had been preheated to 45 °C and gently shaken to dissolve well before incubation overnight at 36 °C. The mixture (10 ml) was then pipetted into 90 ml sterile Enterobacteriaceae enrichment broth and incubated at 36 °C. After overnight incubation, the enrichment broth was streaked on crystal violet neutral red bile salt glucose agar plates and incubated at 36 °C overnight. Any resulting purple or pink colonies were streaked for single colony isolation on tryptic soy agar (TSA) plates which were incubated at 25 °C for up to 72 h. Colonies from the TSA agar plates were picked, and identified using API 20E phenotyping kits as well as the oxidase test. These strains were then archived at − 80 °C using magnetic beads until recovery on TSA for this study.

Genome sequence

Genomic DNA of the bacteria was extracted by the cetyl trimethyl ammonium bromide(CTAB) method and sent to the Beijing Novogene Bioinformatics Technology Co. Ltd. for processing. The harvested DNA was quantified by Qubit before WGS was performed using the Illumina HiSeq 2500-PE150 platform with massively parallel sequencing (MPS) Illumina technology. The sequences were A-tailed, ligated to paired-end adaptors and PCR amplified with a 350 bp insert and a mate-pair library with an insert size of 6 kb for library construction.

Genome assembly

Illumina PCR-adapter reads and low-quality reads from the paired-end and mate-pair libraries were filtered by the quality control step of the coupling pipeline. All good-quality paired reads were assembled into scaffolds using SOAP de novo (version 2.04) software [31, 32]. The filtered reads were then used for gap closing and genome assembly. And the sequences have been deposited in the PubMLST database under The PubMLST ID number listed in Table 1.

MLST analysis

Cronobacter 7-loci MLST profiling was performed by submitting the FASTA genome sequences to the curator (SJF) of the open access Cronobacter PubMLST database (https://pubmlst.org/cronobacter/). The 7-loci being ATP synthase b chain (atpD), elongation factor G (fusA), glutaminyl tRNA synthetase (glnS), glutamate synthase large subunit (gltB), DNA gyrase subunit B (gyrB), translation initiation factor IF-2 (infB) and phosphoenolpyruvate synthase A (ppsA). Speciation of Cronobacter strains was achieved by phylogenetic analysis of the fusA allele sequence [1, 5, 33]. The sequence types (ST) and clonal complexes (CC) for the isolates were predicted using the BIGSdb tools within the database [5].

O-serotype, galF and gnd loci determination analysis

The galF and gnd loci, flanking genes for the O-serotype region, were assigned from the uploaded genome sequences using the BIGSdb tools within the PubMLST database [34]. The O-antigen was then predicted from the galF and gnd loci as according to Ogrodzki & Forsythe [34].

Phylogenetic analyses of C. sakazakii ST13 strains based on SNP differences

WGS was undertaken for SNP analysis of the 32 strains belonged to C. sakazakii ST13 using SMALT and SAMtools [35, 36]. The SNP calling was done independently for each cluster using the earliest isolate within the cluster as the index strain. The resulting variant call format(VCF) files were filtered using VCFTools to include only SNPs with minimum quality score of 30, minimum depth of 8.0, and minimum allele frequency of 0.90 [3739]. SNPs in each cluster were concatenated and used to create a maximum likelihood phylogeny by using RAxML with the GTR-gamma model [40]. The resulting trees were visualised and annotated using Figtree (http://tree.bio.ed.ac.uk/software/figtree/).

Results

Re-identification of archived E. sakazakii strains

Fifty-two bacterial strains which had been isolated in 2005–2006 from imported dairy products and identified using phenotyping as E. sakazakii were re-identified using fusA allele sequencing. The majority (49/52) of strains were identified as C. sakazakii (Additional file 1: Figure S1). The remaining three strains (CS-22, CS-23, & CS-35) were identified as Escherichia coli, Franconibacter helveticus, and Enterobacter cloacae respectively.

MLST analysis of Cronobacter isolates

The MLST results for the 49 C. sakazakii isolates are summarized in Table 1. There was relatively low diversity across the C. sakazakii strains. The majority (32/49) of strains were in sequence type 13 (ST13), with the remaining strains in ST4 (6), ST375 (4), ST1 (2), ST21 (2), ST12 (1), ST42 (1), and ST233 (1). Ten of the ST13 strains had been isolated from PIF. The remaining strainsr were from dairy product ingredients (8), milk powder (7), cheese (5), and other dairy products (2). The six C. sakazakii ST4 strains (pathovar associated with neonatal meningitis) were from milk powder, cheese, other dairy products and dairy product ingredients; Table 1. None were from PIF. They had been imported from USA, New Zealand, and Italy. Four (8.1%) isolates belong to ST375 and had been isolated from dairy products and dairy product ingredients. The remaining C. sakazakii strains had been isolated from dairy product ingredients and dairy products other than PIF, milk powder or cheese.

The strains of E. coli, E. cloacae and F. helveticus which had been mis-identified as C. sakazakii, had been isolated from PIF and dairy product ingredients.

Predicted O-serotype

The O-serotype was predicted based on the DNA sequence of the flanking genes galF and gnd, as according to the in silico scheme of Ogrodzki and Forsythe (2015) [31]. The 32 ST13 strains were all serotype Csak O:2, galF 25 and gnd 28. They were therefore indistinguishable; Table 1. The Csak O:2 serotype was not unique to ST13 as it was also found in the four ST4 strains with the corresponding loci galF3 and gnd2. No serotype could be assigned to ST4 strains with loci galF 4 and gnd 45, as no O-antigen genes has been reported to date with these flanking loci. Similarly, no serotype could be allocated to the 7 strains in ST375 (4), ST12 (1), ST42 (1) or ST233 (1). Only two C. sakazakii O-serotypes were found (Csak O:1 & O:2), whereas there were 8 loci variants of galF and gnd.

WGS-SNP analysis of C. sakazakii belonging to ST13

Due to the highly level of clonality with the C. sakazakii species, 7-loci MLST is unable to distinguish between unrelated strains within the same sequence type [1, 5]. It was considered highly probably that some of the 32 ST13 strains were unrelated since they had been originally isolated from different dairy products imported from various countries; Australia, New Zealand, France, USA, Belgium and Netherlands. Therefore the 32 ST13 isolates were whole genome sequenced for further genotyping and SNP analysis. The earliest isolate of this cluster was C. sakazakii CS-1 isolated from dairy product ingredients imported from USA in 2005. This strain was used as the index strain for SNP calls in order to determine strain relatedness. The SNP differences for each of the strains was determined using SAMTools and the SNP phylogeny was constructed (Fig. 2).

The SNP tree topology showed the 32 strains formed five clusters and five single isolates. There was no pattern with respect to country of origin, or dairy product with any of the clusters. The SNP differences were mainly < 60, except for CS71 which had 5387 SNPs. The five strains in cluster 1 had a high degree of similarity with the index strain as shown by the small number of SNPs different; a maximum of 11 SNP. Cluster 5 was more diffuse than the other 4 clusters I had the largest number of strains (12) with between 4 and 11 SNP differences to the index strain CS1.

Discussion

MLST is regarded as an unambiguous and expansive method for the differentiation of strains in the Cronobacter genus, with the number of loci varying between 7 for conventional MLST, 51 with ribosomal-MLST, and 1836 with core-genome MLST [1, 5]. It is considerably more reliable than phenotyping using commercial kits which is reported to have an accuracy of between 43.2–88.9% for members of the Cronobacter genus [41]. The fusA allele is congruent with the phylogeny of the genus and can be used for speciation [33]. The remaining 6 alleles can then be determined for 7-loci MLST profiling. The 52 strains previously identified as E. sakazakii were re-identified using fusA allele sequence phylogeny. This revealed that the original isolation and phenotyping-based detection method had mis-identified three strains of E. coli, E. cloacae and F. helveticus as E. sakazakii. Such mis-identifications may have resulted in product rejection at port of entry due to the false positive result. This reinforces the need to apply DNA-sequence based methods rather than out of date phenotyping methods for identifying presumptive Cronobacter isolates, especially when regulatory action may be taken.

The remaining 49 isolates were all strains of C. sakazakii. These strains were in 8 sequence types, three of which were represented by only a single isolate. These strains had originated from Oceania, Europe and North America (Fig. 1). The most frequently occurring sequence type was C. sakazakii ST13 (66%, 32/49). The ST13 strains were from various dairy products imported from six countries, though half (16/32) were from New Zealand. Ten strains had been isolated from PIF, and these had primarily (9/10) been imported from New Zealand. In 1994, 26 isolates of C. sakazakii were obtained from an outbreak at a neonatal intensive care unit (NICU) in France that lasted over 3 months and claimed the lives of three neonates; 5 of the 26 isolates were ST13 [6, 18]. In addition, PIF was linked to a neonatal death due to C. sakazakii ST4 infection in New Zealand in 2004, which was close to the sampling period of this study [42]. Therefore, the presence of C. sakazakii ST13 in the PIF imported into China indicates that there was some risk of infection to infants in 2005–2006. Nevertheless, there were no reported cases of Cronobacter infections in neonates or infants in China until 2014 [43].
Figure 1
Fig. 1

Population diversity of the C. sakazakii strains from dairy products accordingto sequence type and country of origin. Figure was generated using the GoeBURSTalgorithm. The threshold for the output was set to triple locus variation. "n=1" represents the number of isolates in the pie chart. The dominant STs are representedby the circles with larger diameters

C. sakazakii ST4 was the second most prominent ST isolated (12%, 6/49). This sequence type is highly significant as it is the pathovar which is strongly associated with neonatal meningitis [1, 44, 45]. Although none of the isolates had been isolated from PIF, the six ST4 strains had been isolated from PIF ingredients (whey powder and whey protein powder), as well as cheese, milk powder and other dairy products. These had been imported from USA, Italy, and New Zealand, reflecting the wide distribution of this sequence type in food products.

Two isolates (CS-24, CS-49), isolated from milk powder and other dairy goods imported from New Zealand were C. sakazakii ST1. This sequence type is associated with clinical infections and some cases of neonatal meningitis [1, 44, 45]. There was one ST12 C. sakazakii isolate from dairy products from New Zealand. This is the C. sakazakii pathovar associated with necrotizing enterocolitis in neonates [1, 5, 7, 44].

Four strains of ST375 (8%, n = 4) had been isolated between 2005 and 2006. These belong to clonal complex 73 (CC73), being a single locus SNP variant of ST73. The PubMLST database only has one other record of C. sakazakii ST73 isolation in China, which from imported food in 2009. The remaining strains in this study comprised of single strains of ST42 and ST233 which had been isolated from imports from Poland and New Zealand.

At the national level, more than half of the C. sakazakii isolates (24/49) were from New Zealand. These isolates were heterogenous, belonging to six sequence types, of which ST13 was the most abundant at 66.7% (Fig. 1). However, the Cronobacter PubMLST database, only contains the records of three C. sakazakii isolates from New Zealand other than those reported here, and none were ST13. However, PIF was linked to a fatal neonatal infection by C. sakazakii ST4 in New Zealand in 2004, 2 years before the sampling period of this study [38]. The strains from the USA consisted of only ST13 and ST4. Compared with other countries, the USA had the most C. sakazakii meningitic ST4 pathovar isolates (3/9). Meanwhile, France, Australia, the Netherlands, and Belgium have only one sequence type; ST13.

In terms of product categories, C. sakazakii ST13 was recovered from five types of dairy products. It is notable that all strains isolated from PIF belonged to ST13. Dairy product ingredients containing C. sakazakii ST13 included whey powder and whey protein powder, which are used for the production of PIF. Dairy product ingredients had a range of C. sakazakii sequence types, including ST13 and ST4, which indicates that imported dairy product ingredients are still a risk to infant health. Six isolates were from cheese, of which one was ST4 and the remaining five belonged to ST13. This indicates that cheese, as a food which may be consumed daily, also poses a risk to people’s health. However, whether Cronobacter infection in adults is due to contaminated food consumption is unproven [46]. The remaining 10 strains were from seven sequence types, reflecting their high diversity. Overall, these results indicate that imported dairy products on the Shanghai market were occasionally contaminated with C. sakazakii between 2005 and 2006.

PCR-probe based serotyping of Cronobacter spp. has been used to define 15 serotypes, of which 5 occur in C. sakazakii. Many of the serotypes are common across different species and, some were originally assigned to the wrong species due to strain mis-identification. This is therefore less discriminatory than 7-loci MLST with 645 variants to date. Ogrodzki & Forsythe (2015) proposed an alternative more reliable and discriminatory approach by in silico analysis of the galF and gnd genes which flank the O-antigen operon [34]. Table 1 shows the variation on O-serotype for the strains. Of particular interest was that all ST13 strains corresponded to Csak O: 2. Similarly, the ST13 strains from the 1994 NICU outbreak in France were serotype Csak O: 2 [34].

Since Cronobacter is a highly clonal genus, conventional genotyping methods are limited as they cannot always distinguish unrelated strains [1, 20]. This occurs with the application of PFGE and MLST with Salmonella and Cronobacter. This limitation can cause confusion and is one of the reasons for PulseNet changing to the application of WGS-SNP analysis [21, 22]. In this study, the C. sakazakii ST13 strains had been isolated from 6 countries and different dairy products. They were therefore likely to be unrelated, and so WGS-SNP analysis was undertaken to distinguish between these strains within the same sequence type.

Figure 2 shows the SNPs tree analysis for the ST13 isolates with comparison to ST13 strain CS-1. The strains divided into 5 clusters based on the analytic parameters of times, locations and whole-genome SNPs. Thus, confirming that strains within the same ST are distinguishable. The small number of SNP differences was unexpected but may reflect the high clonality of the organism, which is also shown in the small variation reported for CRISPR-cas array profiles for strains within an ST which differ in their geographical and temperal sources [47, 48].
Figure 2
Fig. 2

SNP phylogeny of C. sakazakii strains belonged to ST13. The SNPs werecalled using SMALT and SAMtools to generate the VCF files which were filtered usingVCFTools to include only SNPs with minimum quality score of 30, minimum depth of 8,and minimum allele frequency of 0.90. The SNPs in the cluster were concatenated andused to create a maximum likelihood phylogeny. The tree was rooted to midpoint. C.sakazakii CS-1 was the reference strain. The scale bar indicates the rate of nucleotidedifferences per sequence site

Conclusion

The previous method, based on phenotyping, for the detection and identification of E. sakazakii from imported dairy products had resulted in false positive results for other Enterobacteriaceae; E. coli, E. cloacae and F. helveticus. The application of DNA-sequence based methods, such as 7-loci MLST, provides a more reliable means of identifying and genotyping presumptive Cronobacter isolates. The majority of formerly identified E. sakazakii isolates from imported dairy products were C. sakazakii, and included the pathovars ST4 and ST1. In this study the predominant sequence type was ST13 from dairy products imported from New Zealand. Due to the highly degree of clonality in the Cronobacter genus 7-loci MLST is unable to distinguish unrelated strains of C. sakazakii. Therefore, combining WGS-SNP with isolation date and geolocation is a better method for genotyping C. sakazakii, as it is traceable and allows the data to be shared worldwide. This approach considerably improves the success rate of food-borne pathogen traceability and surveillance, and subsequently are important for the protection of public health. In addition, WGS data can be used for studies beyond outbreak investigations, such as the detection of antibiotic resistance, virulence and thermotolerance genes.

Notes

Abbreviations

BIGSdb: 

Bacterial Isolate Genome Sequence database

CTAB: 

cetyl trimethyl ammonium bromide

FDA: 

Food and drug administration

ICMSF: 

the International Commission on Microbiological Specifications for Foods

MLST: 

Multi-locus sequence typing

MPS: 

Massively parallel sequencing

ST: 

Sequence type

STEC: 

Shiga toxin-producing E. coli

TSA: 

Tryptic soy agar L

VCF: 

variant call format

VRE: 

Vancomycin-resistant enterococci

WGS-SNP: 

Whole genome sequence with single nucleotide polymorphism analysis

Declarations

Acknowledgements

This publication made use of the Cronobacter Multi Locus Sequence Typing website (http://pubmlst.org/cronobacter/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden [49]). The development of this site has been funded by the Wellcome Trust. The authors thank our numerous collaborators especially those involved who have submitted sequences to the Cronobacter PubMLST database.

Funding

This work was supported by National Natural Science Foundation of China (31671936) from the Ministry of Science and Technology of People’s Republic of China, in 2017. The funding bodies provided the fund for the research work and they were not involved in design of the study and data collection, analysis and interpretation of data and writing the manuscript.

Authors’ contributions

QYG: Initiated the study and wrote initial draft of the manuscript. SJF: Proposed amendments, contributed to the writing of the final version of the manuscript. JLY & YJ: managed the project designed the study, and contributed to the writing of the final version of the manuscript. WH, YPH, BN, and SJF reviewed and edited the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Shanghai Customs (former Shanghai Entry-Exit Inspection and Quarantine Bureau), Shanghai, People’s Republic of China
(2)
Technical Center for Animal, Plant and Food Inspection and Quarantine, Shanghai Entry-Exit Inspection and Quarantine Bureau, Shanghai, People’s Republic of China
(3)
foodmicrobe.com, Adams Hill, Nottinghamshire, UK
(4)
Shanghai University, Shanghai, People’s Republic of China

References

  1. Forsythe S. Updates on the Cronobacter genus. Annu Rev Food Sci Technol. 2018;9:23–44.View ArticlePubMedGoogle Scholar
  2. Joseph S, Cetinkaya E, Drahovska H, Levican A, Figueras MJ, Forsythe SJ. Cronobacter condimenti sp. nov., isolated from spiced meat, and Cronobacter universalis sp. nov., a species designation for Cronobacter sp. genomospecies 1, recovered from a leg infection, water and food ingredients. Int J Syst Evol Microbiol. 2012a;62:1277–83.View ArticlePubMedGoogle Scholar
  3. Joseph S, Sonbol H, Hariri S, Desai P, McClelland M, Forsythe SJ. Diversity of the Cronobacter genus as revealed by multilocus sequence typing. J Clin Microbiol. 2012c;50:3031–9.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Holy O, Forsythe S. Cronobacter spp. as emerging causes of healthcare-associated infection. J Hosp Infect. 2014;86:169–77.View ArticlePubMedGoogle Scholar
  5. Forsythe SJ, Dickins B, Jolley KA. Cronobacter, the emergent bacterial pathogen Enterobacter sakazakii comes of age; MLST and whole genome sequence analysis. BMC Genomics. 2014;15:1121.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Caubilla-Barron J, Hurrell E, Townsend S, Cheetham P, Loc-Carrillo C, Fayet O, et al. Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France. J Clin Microbiol. 2007;45:3979–85.View ArticlePubMedPubMed CentralGoogle Scholar
  7. van Acker J, de Smet F, Muyldermans G, Bougatef A, Naessens A, Lauwers S. Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula. J Clin Microbiol. 2001;39:293–7.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Minor T, Lasher A, Klontz K, Brown B, Nardinelli C, Zorn D. The per case and total annual costs of foodborne illness in the United States. Risk Anal. 2015;35:1125–39.View ArticlePubMedGoogle Scholar
  9. Friedemann M. Enterobacter sakazakii in food and beverages (other than infant formula and milk powder). Int J Food Microbiol. 2007;116:1–10.View ArticlePubMedGoogle Scholar
  10. Siqueira Santos RF, da Silva N, Amstalden Junqueira VC, Kajsik M, Forsythe S, Pereira JL. Screening for Cronobacter species in powdered and reconstituted infant formulas and from equipment used in formula preparation in maternity hospitals. Ann Nutr Metab. 2013;63:62–8.View ArticlePubMedGoogle Scholar
  11. Shaker R, Osaili T, Al-Omary W, Jaradat Z, Al-Zuby M. Isolation of Enterobacter sakazakii and other Enterobacter sp. from food and food production environments. Food Control. 2007;18:1241–5.View ArticleGoogle Scholar
  12. Turcovský I, Kunikova K, Drahovska H, Kaclikova E. Biochemical and molecular characterization of Cronobacter spp. (formerly Enterobacter sakazakii) isolated from foods. Antonie Van Leeuwenhoek. 2011;99:257–69.View ArticlePubMedGoogle Scholar
  13. Caubilla-Barron J, Forsythe S. Dry stress and survival time of Enterobacter sakazakii and other Enterobacteriaceae. J Food Protect. 2007;70:2111–7.View ArticleGoogle Scholar
  14. International Commission on Microbiological Specifications for Foods(ICMSF). Microorganisms in food 7: microbiological testing in food safety management. In: Accessed; 2002.Google Scholar
  15. Kluwer Academic/Plenum Publishers. Microorganisms in Food 7. In: Microbiological testing in food safety management. International Commission on Microbiological Specifications for Foods(ICMSF). 2002. https://link.springer.com/book/10.1007%2F978-1-4684-8369-7. Accessed 15 Jan 1999.
  16. Muytjens HLZH, Sonderkamp HJ, Kollée LA, Wachsmuth IK, Farmer JJ. Analysis of eight cases of neonatal meningitis and Sepsis due to Enterobacter sakazakii. J Clin Microbiol. 1983;18:115–20.PubMedPubMed CentralGoogle Scholar
  17. Himelright I, Harris E, Lorch V, Anderson M, Jones T, Craig A, et al. From the Centers for Disease Control and Prevention. J Am Med Assoc. 2002;287:2204.View ArticleGoogle Scholar
  18. Masood N, Moore K, Farbos A, Paszkiewicz K, Dickins B, McNally A, et al. Genomic dissection of the 1994 Cronobacter sakazakii outbreak in a French neonatal intensive care unit. BMC Genomics. 2015;16:750.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Stranden A, Frei R, Widmer AF. Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis? J Clin Microbiol. 2003;41:3181–6.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Alsonosi A, Hariri S, Kajsik M, Orieskova M, Hanulik V, Roderova M, Petrzelova J, Kollarova H, Drahovska H, Forsythe S, Holy O. The speciation and genotyping of Cronobacter isolates from hospitalised patients. Euro J Clin Microbiol. 2015;34:1979–88.View ArticleGoogle Scholar
  21. Nadon C, Walle IV, Gernersmidt P. PulseNet International: Vision for the implementation of whole genome sequencing (WGS) for global food-borne disease surveillance. Euro Surveill. 2017;22(23).Google Scholar
  22. Scharff RL, Besser J, Sharp DJ, Poe A, Zhang P, Concepción-Acevedo J, et al. An Economic Evaluation of PulseNet: A Network for Foodborne Disease Surveillance. Am J Prev Med. 2016; 50(5):S66–73.Google Scholar
  23. Kozyreva VK, Crandall J, Sabol A, Poe A, Zhang P, Concepción-Acevedo J, et al. Laboratory Investigation of Salmonella entericaserovar Poona Outbreak in California: Comparison of Pulsed-Field GelElectrophoresis (PFGE) and Whole Genome Sequencing (WGS) Results. PLoS Curr. 2016; 8:97–8.Google Scholar
  24. Lytsy B, Engstrand L, Gustafsson A, Kaden R. Time to review the gold standard for genotyping vancomycin-resistant enterococci in epidemiology: comparing whole-genome sequencing with PFGE and MLST in three suspected outbreaks in Sweden during 2013-2015. Infect Genet Evol. 2017;54:74–80.View ArticlePubMedGoogle Scholar
  25. McRobb E, Sarovich DS, Price EP, Kaestli M, Mayo M, Keim P, et al. Tracing melioidosis back to the source: using whole-genome sequencing to investigate an outbreak originating from a contaminated domestic water supply. J Clin Microbiol. 2015;53:1144–8.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Ferdous M, Friedrich AW, Grundmann H, de Boer RF, Croughs PD, Islam MA, et al. Molecular characterization and phylogeny of Shiga toxin-producing Escherichia coli isolates obtained from two Dutch regions using whole genome sequencing. Clin Microbiol Infect. 2016;22(642):641–9.Google Scholar
  27. US Food and Drug Administration Center for Food Safety and Applied Nutrition: Isolation and enumeration of Enterobacter sakazakii from dehydrated powdered infant formula. 2002.Google Scholar
  28. Microbial detection of Enterobacter sakazakii: Food and clinical. https://www.fda.gov/food/foodscienceresearch/laboratorymethods/ucm289378.htm.
  29. Kandhai MC, Reij MW, vall Puyvelde K. A new protocol for the detection of Enterobacter sakazakii applied to environmental samples. J Food Prot. 2004;67:1267–70.View ArticlePubMedGoogle Scholar
  30. Government of Canada Laboratory Procedure. MFUP-27. The Dupont oualicon BAX system method for the detection of Enterobacter sakazakii in selected foods. Health products and food branch ATTA WA. Accessed Sep 2003.Google Scholar
  31. Li R, Zhu H, Ruan J, Qian W, Fang X, Shi Z, et al. De novo assembly of human genomes with massively parallel short read sequencing. Genome Res. 2010;20:265–72.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Li R, Li Y, Kristiansen K, Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics. 2008;24:713–4.View ArticlePubMedGoogle Scholar
  33. Joseph S, Desai P, Ji Y, Cummings CA, Shih R, Degoricija L, et al. Comparative analysis of genome sequences covering the seven Cronobacter species. PLoS One. 2012b;7:e49455.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Ogrodzki P, Forsythe S. Capsular profiling of the Cronobacter genus and the association of specific Cronobacter sakazakii and C. malonaticus capsule types with neonatal meningitis and necrotizing enterocolitis. BMC Genomics. 2015;16:758.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–9.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Lorenc MT, Hayashi S, Stiller J, Lee H, Manoli S, Ruperao P, et al. Discovery of single nucleotide polymorphisms in complex genomes using SGSautoSNP. Biology. 2012;1:370–82.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Sahl JW, Steinsland H, Redman JC, Angiuoli SV, Nataro JP, Sommerfelt H, et al. A comparative genomic analysis of diverse clonal types of enterotoxigenic Escherichia coli reveals pathovar-specific conservation. Infect Immun. 2011;79:950–60.View ArticlePubMedGoogle Scholar
  38. Clark G, Paszkiewicz K, Hale J, Weston V, Constantinidou C, Penn C, et al. Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections. J Antimicrob Chemother. 2012;67(4):868–77.View ArticlePubMedGoogle Scholar
  39. McNally A, Alhashash F, Collins M, Alqasim A, Paszckiewicz K, Weston V, et al. Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis. Clin Microbiol Infect. 2013;19:328–34.View ArticleGoogle Scholar
  40. Stamatakis A, Ludwig T, Meier H. RAxML-III: a fast program for maximumlikelihood-based inference of large phylogenetic trees. Bioinformatics. 2005;21:456–63.View ArticlePubMedGoogle Scholar
  41. Jackson EE, Forsythe SJ. Comparative study of Cronobacter identification according to phenotyping methods. BMC Microbiol. 2016;16(1):146.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Jarvis C. New investigator award, blue ribbon abstract award. Am J Infect Control. 2005;33:19.View ArticleGoogle Scholar
  43. Cui JH, Du XL, Wei RJ, Zhou HJ, Li W, Forsythe S, Cui ZG. Multilocus sequence typing analysis of Cronobacter spp. isolated from China. Arch Microbiol. 2015;197:665–72.View ArticlePubMedGoogle Scholar
  44. Joseph S, Forsythe SJ. Predominance of Cronobacter sakazakii sequence type 4 in neonatal infections. Emerg Infect Dis. 2011;17:1713–5.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Hariri S, Joseph S, Forsythe SJ. Cronobacter sakazakii ST4 strains and neonatal meningitis, United States. Emerg Infect Dis. 2013;19:175–7.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Brandao MLL, Umeda NS, Jackson E, Forsythe SJ, de Filippis I. Isolation, molecular and phenotypic characterization, and antibiotic susceptibility of Cronobacter spp. from Brazilian retail foods. Food Microbiol. 2017;63:129–38.View ArticlePubMedGoogle Scholar
  47. Ogrodzki P, Forsythe SJ. Clustered regularly interspaced short palindromic repeats (CRISPRs)-cas loci profiling of Cronobacter sakazakii pathovars. Future Microbiol. 2016;11:1507–19.View ArticlePubMedGoogle Scholar
  48. Ogrodzki P, Forsythe SJ. DNA-sequence based typing of the Cronobacter genus using MLST, CRISPR-cas array and capsular profiling. Front Microbiol. 2017;8:1875.View ArticlePubMedPubMed CentralGoogle Scholar
  49. Jolley KA, Maiden MC. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinform. 2010;11:595.View ArticleGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement